During the past decade, Sound Pharmaceuticals, Inc. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sound Pharmaceuticals, Inc." are "Meniere's Disease" (1 trials) and "Noise Induced Hearing Loss" (1 trials). Many other conditions were trialed in "Sound Pharmaceuticals, Inc." in a lesser frequency.

Most popular intervention types in "Sound Pharmaceuticals, Inc." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "SPI-1005" (1 trials), "SPI-1005 200mg" (1 trials) and "SPI-1005 400mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sound Pharmaceuticals, Inc." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sound Pharmaceuticals, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sound Pharmaceuticals, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sound Pharmaceuticals, Inc., 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".